首页> 外文期刊>Acta Poloniae Pharmaceutica: Durg Research >Development and validation of RP-HPLC method for simultaneous estimation of nimesulide, phenylephrine hydrochloride, chlorpheniramine maleate and caffeine anhydrous in pharmaceutical dosage form
【24h】

Development and validation of RP-HPLC method for simultaneous estimation of nimesulide, phenylephrine hydrochloride, chlorpheniramine maleate and caffeine anhydrous in pharmaceutical dosage form

机译:建立同时测定药物剂型中尼美舒利,盐酸去氧肾上腺素,马来酸氯苯那敏和咖啡因的RP-HPLC方法的建立和验证

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, a simple, specific and accurate reverse phase high performance liquid chromatographic method was developed for the simultaneous determination of nimesulide (NS), phenylephrine hydrochloride (PE), chlorpheniramine maleate (CPM) and caffeine anhydrous (CF) in pharmaceutical dosage forms. A reversed phase Hypersil phenyl column (4.6 mm x 25 cm) with mobile phase having pH 5.5 consisting of methanol and buffer (55:45, v/v) was used. The flow rate was 1.0 mL per minute and the effluents were monitored at 214 nm. The retention times of all the drugs were found to be 7.47 min (NS), 3.944 min (PE), 4.55 min (CF) and 17.15 min (CPM), respectively. The linearity for all the drugs was obtained in the range of 300-800 μg/mL (NS), 15-32 μg/mL (PE), 16-32 μg/mL (CPM) and 30-180 μg/mL (CF), respectively. The results of analysis have been well validated according to guidelines of International Conference of Harmonisation of technical requirements for registration of pharmaceuticals for human use. The method was found to be simple, precise, economical, less time consuming and reproducible. Hence, the suggested procedure could be used for the determination of all the four drugs in commercial preparations.
机译:在这项研究中,开发了一种简单,特异性和准确的反相高效液相色谱方法,用于同时测定药物剂型中的尼美舒利(NS),盐酸去氧肾上腺素(PE),马来酸氯苯那敏(CPM)和无水咖啡因(CF) 。使用具有甲醇和缓冲液(55:45,v / v)组成的pH 5.5流动相的反相Hypersil苯基色谱柱(4.6 mm x 25 cm)。流速为每分钟1.0 mL,并在214 nm处监测流出液。发现所有药物的保留时间分别为7.47分钟(NS),3.944分钟(PE),4.55分钟(CF)和17.15分钟(CPM)。所有药物的线性范围为300-800μg/ mL(NS),15-32μg/ mL(PE),16-32μg/ mL(CPM)和30-180μg/ mL(CF ), 分别。分析结果已经按照国际人用药品注册技术要求协调会议的指南得到了很好的验证。发现该方法简单,精确,经济,耗时少且可重复。因此,建议的程序可用于测定商业制剂中所有四种药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号